Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity

a week ago

HOUSTON, Oct. 08, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( NASDAQ:BPTH ) , a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced the initiation of a ...

Ticker	Sentiment	Impact
BPTH	Somewhat Bullish	40 %